Paula Marazuela

CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2 N141I neurons

Maitane Ortiz‐Virumbrales, Cesar L. Moreno, Ilya Kruglikov et al. · Acta Neuropathologica Communications · 2017 · 170 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis

Sofía Fernández-de-Retana, Mary Cano‐Sarabia, Paula Marazuela et al. · Scientific Reports · 2017 · 52 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice

Sofía Fernández de Retana, Paula Marazuela, Montse Solé et al. · Alzheimer s Research & Therapy · 2019 · 52 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease

Sofía Fernández-de Retana, Alex Montañola, Paula Marazuela et al. · Neurobiology of Aging · 2017 · 40 citations

Life Sciences, Neuroscience, Pharmacology +17

Survival Bias and Crosstalk between Chronological and Behavioral Age: Age- and Genotype-Sensitivity Tests Define Behavioral Signatures in Middle-Aged, Old, and Long-Lived Mice with Normal and AD-Associated Aging

Lydia Giménez‐Llort, Daniela Marín-Pardo, Paula Marazuela et al. · Biomedicines · 2021 · 31 citations · Full text

Education, Neurology, Neuroscience +17